Characterization of the relaxant action of urocortin, a new peptide related to corticotropin-releasing factor in the rat isolated basilar artery

British Journal of Pharmacology

Volumn 125, Issue 6, 1998, Pages 1164-1171

  Schilling, L ^a,c   Kanzler, Ch ^a   Schmiedek, P ^a   Ehrenreich, H ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adenylate cyclase; Ca2+ dependent K+ channels; Cerebral artery; CRF related peptides; Urocortin

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; APAMIN; CORTICOTROPIN RELEASING FACTOR; HYPOTHALAMUS RELEASING FACTOR; IBERIOTOXIN; NEUROPEPTIDE; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN F2 ALPHA; SAUVAGINE; TETRYLAMMONIUM; UROCORTIN;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; ISOLATED ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOMOTOR REFLEX;

EID: 0031742859     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702182     Document Type: Article

References (45)

1. 1 receptor mRNA expression. J. Neurosci., 15, 6340-6350.
2. CHALMERS, D.T., LOVENBERG, T.W., GRIGORIADIS, D.E., BEHAN, D.P. & DE SOUZA, E.B. (1996). Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci., 17, 167-172.
3. CHANG, C.-P., PEARSE, R.V., O'CONNELL, S. & ROSENFELD, M.G. (1993). Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron, 11, 1187-1195.
4. CHEN, F.M., BILEZIKJIAN, L.M., PERRIN, M.H., RIVIER, J. & VALE, W. (1986). Corticotropin releasing factor receptor-mediated stimulation of adenylate cyclase activity in the rat brain. Brain Res., 381, 49-57.
5. DIETERICH, K.D., LEHNERT, H. & DE SOUZA, E.B. (1997). Corticotropin-releasing factor receptors: an overview. Exp. Clin. Endocrinol. Diabetes, 105, 65-82.
6. DONALDSON, C.J., SUTTON, S.W., PERRIN, M.H., CORRIGAN, A.Z., LEWIS, K.A., RIVIER, J.E., VAUGHAN, J.M. & VALE, W.W. (1996). Cloning and characterization of human urocortin. Endocrinology, 137, 2167-2170.
7. EHRENREICH, H., SCHUCK, J., STENDER, N., PILZ, J., GEFELLER, O., SCHILLING, L., POSER, W. & KAW, S. (1997a). Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol. Clin. Exp. Res., 21, 1285-1293.
8. EHRENREICH, H., TOM DIECK, K., GEFELLER, O., KAW, S., SCHILLING, L., POSER, W. & RÜTHER, E. (1997b). Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty. Psychoneuroendocrinology, 22, 13-24,
9. FEGER, G.I., SCHILLING, L., EHRENREICH, H. & WAHL, M. (1994). Endothelin induced contraction and relaxation of rat isolated basilar artery: effect of BQ-123. J. Cereb. Blood Flow Metab., 14, 845-852.
10. FOX, M.W., ANDERSON, R.E. & MEYER, F.B. (1993). Neuroprotection by corticotropin releasing factor during hypoxia in rat brain. Stroke, 24, 1072-1076.
11. GULYAS, J., RIVIER, C., PERRIN, M., KOERBER, S.C., SUTTON, S., CORRIGAN, A., LAHRICHI, S.L., CRAIG, A.G., VALE, W. & RIVIER, J. (1995). Potent, structurally constrained agonists and competitive antagonists of coticotropin-releasing factor. Proc. Natl. Acad. Sci. USA, 92, 10575-10579.
12. HARRIS, D.N., ASAAD, M.D., PHILLIPS, M.B., GOLDENBERG, H.J. & ANTONACCIO, M.J. (1979). Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives. J. Cyclic Nucleotide Res., 5, 125-134.
13. KISHIMOTO, T., PEARSE, R.V., LIN, C.R. & ROSENFELD, M.G. (1995). A sauvagine / corticotropin-releasing factor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA, 92, 1108-1112.
14. KSOLL, E., PARSONS, A.A., MACKERT, J.R.L., SCHILLING, L. & WAHL, M. (1991). Analysis of cromakalim-, pinacidil-, and nicorandil-induced relaxation of the 5-hydroxytryptamine precontracted rat isolated basilar artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 377-383.
15. KÜBLER, A., ROTHACHER, G., KNAPPERTZ, V.A., KRÄMER, G., NINK, M., BEYER, J. & LEHNERT, H. (1994). Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone. Clin. Investig., 72, 331-336.
16. LEHNERT, H., NINK, M., MANN, K., RÖSCHKE, J. & HELLHAMMER, D.H. (1993). Extrapituitary effects of corticotropin-releasing hormone and thyrotropin-releasing hormone. Neuropsychobiology, 28, 54-61.
17. LEI, S., RICHTER, R., BIENERT, M. & MULVANY, M.J. (1993). Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Brit. J. Pharmacol., 108, 941-947.
18. LENZ, H.J., FISHER, L.A., VALE, W.W. & BROWN, M.R. (1985). Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow. Amer. J. Physiol., 249, R85-R90.
19. 2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology, 136, 4139-4142.
20. LOVENBERG, T.W., LIAW, C.W., GRIGORIADIS, D.E., CLEVENGER, W., CHALMERS, D.T., DE SOUZA, E.B. & OLTERSDORF, T. (1995b). Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA, 92, 836-840.
21. MACCANNELL, K.L., HAMILTON, P.L., LEDERIS, K., NEWTON, C.A. & RIVIER, J. (1984). Corticotropin releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation. Gastroenterology, 87, 94-102.
22. MACCANNELL, K.L., LEDERIS, K., HAMILTON, P.L. & RIVIER, J. (1982). Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation. Pharmacology, 25, 116-120.
23. MAECKER, H., DESAI, A., DASH, R., RIVIER, J., VALE, W. & SAPOLSKY, R. (1997). Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Res., 744, 166-170.
24. MURRAY, K.J. (1990). Cyclic AMP and mechanisms of vasodilation. Pharmacol. Ther., 47, 329-345.
25. OWENS, M.J. & NEMEROFF, C.B. (1991). Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev., 43, 425-473.
26. PARSONS, A.A., KSOLL, E., MACKERT, J.R.L., SCHILLING, L. & WAHL, M. (1991). Comparison of cromakalim-induced relaxation of potassium pre-contracted rabbit, cat and rat isolated cerebral arteries. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 384-392.
27. + channels in cerebral vasodilatation induced by increases in cyclic GMP and cyclic AMP in the rat. Stroke, 27, 1603-1608.
28. PERRIN, M., DONALDSON, C., CHEN, R., BLOUNT, A., BERGGREN, T., BILEZIKJIAN, L., SAWCHENKO, P. & VALE, W. (1995). Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA, 92, 2969-2973.
29. POTTER, E., SUTTON, S. CHEN, R., PERRIN, M., LEWIS, K., SAWCHENKO, P.E. & VALE, W. (1994). Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA, 91, 8777-8781.
30. REISINE, T. & HOFFMAN, A. (1983). Desensitization of corticotropin-releasing factor receptors. Biochem. Biophys. Res. Commun., 111, 919-925.
31. RICHTER, R.M. & MULVANY, M.J. (1995). Comparison of hCRF and oCRF effects on cardiovascular responses after central, peripheral, and in vitro application. Peptides, 16, 843-849.
32. ROHDE, E., FURKERT, J., FECHNER, K., BEYERMANN, M., MULVANY, M.J., RICHTER, R.M., DENEF, C., BIENERT, M. & BERGER, H. (1996). Corticotropin-releasing hormone (CRF) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol., 52, 829-833.
33. B-type endothelin receptor. J. Cereb. Blood Flow Metab., 15, 699-705.
34. SCHILLING, L., FEGER, G.I., EHRENREICH, H. & WAHL, M. (1996). Cerebrovascular effects of endothelin-3: modulation of contraction by nitric oxide is independent of endothelin B receptor activation. Neurol. Res., 18, 281-285.
35. STRIJBOS, P.J.L.M., RELTON, J.K. & ROTHWELL, N.J. (1994). Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischemia or activation of NMDA receptors in the rat brain. Brain Res., 656, 405-408.
36. + channels. Circ. Res., 76, 1057-1062.
37. VALE, W., SPIESS, J., RIVIER, C. & RIVIER, J. (1981). Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science, 213, 1394-1397.
38. VAN ROSSUM, J.M. (1963). Cumulative dose-response curves II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch. Int. Pharmacodyn., 143, 299-330.
39. VAUGHAN, J., DONALDSON, C., BITTENCOURT, J., PERRIN, M.H., LEWIS, K., SUTTON, S., CHAN, R., TURNBULL, A.V., LOVEJOY, D., RIVIER, C., RIVIER, J., SAWCHENKO, P.E. & VALE, W. (1995). Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature, 378, 287-292.
40. WAHL, M., DEETJEN, P., THURAU, K., INGVAR, D.H. & LASSEN, N.A. (1970). Micropuncture evaluation of the importance of perivascular pH for the arteriolar diameter on the brain surface. Pflügers Arch., 316, 152-163.
41. WEI, E.T. & GAO, G.C. (1991). Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury. Regul. Pept., 33, 93-104.
42. WONG, M.-L., AL-SHEKHLEE, A., BONGIORNO, P.B., ESPOSITO, A., KHATRI, P., STERNBERG, E.M., GOLD, P.W. & LICINO, J. (1996). Localization of urocortin messenger RNA in rat brain and pituitary. Mol. Psychiat., 1, 307-312.
43. YATSUSHIRO, K., CHALMERS, D.T., DE SOUZA, E.B. & MCCULLOCH, J. (1997a). The presence and vasomotor significance of corticotrophin-releasing factor subtypes in feline cerebral arterioles. J. Cereb. Blood Flow Metab., 17, suppl. 1, S287.
44. YATSUSHIRO, K., CHALMERS, D.T., LODDICK, S.A., DE SOUZA, E.B., GRAHAM, D.I. & MCCULLOCH, J. (1997b). The involvement of corticotrophin releasing factor (CRF) in focal cerebral ischemia. J. Cereb. Blood Flow Metab., 17, suppl. 1, S533.
45. YATSUSHIRO, K, CHALMERS, D.T. & MCCULLOCH, J. (1997c). Corticotrophin-releasing factor is a potent dilator of cerebral blood vessels in vivo. J. Cereb. Blood Flow Metab., 17, suppl. 1, S286.